Sheppard, Mullin, Richter & Hampton is acting as U.S. legal advisor to Hepion and Lipa Meir & Co. is acting as Israeli legal advisor to Hepion....
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Unicycive Therapeutics in the transaction. Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, executed its $50...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised ThinkEquity on the transaction. BioVie Inc executed its $21 million public offering of Common Stock and Warrants. ThinkEquity acted as placement agent in the...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Unicycive Therapeutics on the deal. Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney...
You must be a Standard 1 Year member to access this content.
